Indianapolis, IN, United States of America

Arvind L Thakkar

This inventor holds 16 USPTO granted patents, primarily in Pharmaceutical Formulations. Top assignee: Eli Lilly and Company. Active years: 1976-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arvind L Thakkar. Retrieved from https://idiyas.com/inventor/arvind-l-thakkar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 232(Granted Patents)


Company Filing History:


Years Active: 1976-2004

Loading Chart...
Areas of Expertise:
Benzothiophenes
Raloxifene Hydrochloride
Sustained Release
Injectable Formulations
Contraceptive Methods
Polymorphic Crystals
Antibiotic Compositions
Dibenzo[b,d]pyranone
16 patents (USPTO):Explore Patents

Title: The Inventor Arvind L Thakkar

Introduction: Arvind L Thakkar is a renowned inventor based in Indianapolis, IN (US) known for his groundbreaking contributions to various fields.

Latest Patents: Arvind L Thakkar holds several patents in the areas of technology and healthcare, showcasing his innovative mindset and problem-solving abilities.

Career Highlights: Throughout his career, Arvind L Thakkar has been recognized for his inventive spirit and has received numerous awards for his pioneering work in the industry.

Collaborations: Arvind L Thakkar has collaborated with leading companies and research institutions to further develop and implement his innovative ideas, leaving a lasting impact on the field of technology.

Conclusion: Arvind L Thakkar's dedication to innovation and his passion for creating solutions to complex problems have solidified his reputation as a visionary inventor in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…